Podcasts about Social medicine

In a panel discussion hosted by the Sadhguru Center for a Conscious Planet and moderated by Matcheri Keshavan (Professor, Harvard Medical School), Sadhguru, Swami Sarvapriyananda (Minister & Spiritual Leader, Vedanta Society of New York), John Torous (Associate Professor of Psychiatry at Harvard Medical School and Director of Digital Psychiatry at Beth Israel Deaconess Medical Center), Dr. Vikram Patel (Paul Farmer Professor & Chair of Global Health and Social Medicine, Harvard Medical School), and Dr. Shirley Yen (Associate Professor of Psychology, Harvard Medical School) explored artificial intelligence, mental health, and consciousness. The discussion tackled some of humanity's biggest existential questions – whether AI can replace human beings and whether a mental health crisis is imminent. Conscious Planet: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.consciousplanet.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Sadhguru App (Download): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://onelink.to/sadhguru__app⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Official Sadhguru Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://isha.sadhguru.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Sadhguru Exclusive: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://isha.sadhguru.org/in/en/sadhguru-exclusive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

Do you want this? Toronto police caught on tape tackling cyclist who allegedly disobeyed stop signGUESTS: Dr. Andrew Boozary - primary care physician, founder of this project, and founding executive director of the Gattuso Centre for Social Medicine at UHN

The housing crisis is fundamentally a health problem. Decades of research show that people experiencing homelessness spend twice as long in the hospital, cost the healthcare system double and have a life expectancy half that of the average Canadian. In this special episode of Solve for X: Innovations to Change the World, recorded live at a MaRS Morning event, host Manjula Selvarajah sits down with primary care physician Dr. Andrew Boozary to discuss a radical shift in Canadian medicine: treating housing not just as a social service, but as a critical medical intervention. As founding executive director of UHN's Gattuso Centre for Social Medicine, Boozary shares data-driven insights from his initiatives there: prescribing nutritious food boxes, the launch of Ontario's first hospital-based homelessness and eviction program and, most famously, the establishment of Dunn House, a permanent supportive housing model that's proven to be both effective and scalable. Together, Selvarajah and Boozary explore what it takes to dismantle bureaucratic sludge, cut through systematic fragmentation and build a healthcare system rooted in human dignity. Dr. Andrew Boozary is a primary care physician and the founding executive director of the Gattuso Centre for Social Medicine at University of Health Network (UHN). At the forefront of health equity and public policy, his work focuses on integrating social determinants of health — such as housing, income and food security — directly into patient care. Boozary has spearheaded pioneering social medicine models including Toronto's modular permanent supportive housing project, Dunn House, establishing crucial healthcare interventions that drastically improve health outcomes while reducing healthcare costs. In 2026, he received a Governor General's Innovation Award for developing Dunn House. Further reading Dr. Andrew Boozary on expanding social medicine housing model Dunn HousePathologies of poverty: The need for housing Dunn House gave homeless ER patients a home and saved Toronto hospitals millions. Now they're building another oneHow did social medicine evolve, and where is it heading? Subscribe to Solve for X: Innovations to Change the World here.    Solve for X is brought to you by MaRS, North America's largest urban innovation hub and a registered charity. MaRS supports startups and accelerates the adoption of high-impact solutions to some of the world's biggest challenges. For more information, visit marsdd.com.

In this episode, we are joined by Dr. Katherine Peeler, founding director of the Peeler Immigration Lab, to discuss her longstanding empirical work on human rights and US immigration systems. Dr. Peeler is an Associate Physician in Pediatrics at the Boston Children's Hospital and Assistant Professor of Pediatrics, Global Health and Social Medicine at Harvard Medical School. She is a faculty member of the Harvard Medical School Center for Bioethics. Dr. Peeler describes her longstanding interest in building an evidence base of health effects of human rights abuses as a means of changing policy. Her interest in this field was initially sparked by the work of Paul Farmer and Partners in Health and their mission to improve direct care to patients. She was drawn specifically to challenges facing asylum seekers in the US and shifted towards policy work with Physicians for Human Rights. She founded the Peeler Lab during the COVID pandemic out of concern for people facing the pandemic in detention. Her lab has focused on writing for a public and policy audience to improve conditions and health of immigrants. More recently, her work has focused on solitary confinement in Immigration and Customs Enforcement (ICE) facilities. She painstakingly documents the multiple human rights violations, record number of deaths in these facilities, and violations of United Nations (UN) minimal standards for treatment of detained individuals. Policies for solitary confinement or "restricted housing" meet UN criteria for torture. She outlines strategies that States and local governments can employ to improve oversight and limit expansion of these facilities. The episode wraps up with a discussion of the role of bioethicists to forge common language across opposition and help parties understand shared values and have more productive conversations.Peeler Lab: https://peelerimmigrationlab.hsites.harvard.edu/Publications:"Praying for Hand Soap and Masks:" Health and Human Rights Violations in U.S. Immigration Detention during the COVID-19 Pandemic.”“Endless Nightmare” Torture and Inhuman Treatment in Solitary Confinement in U.S. Immigration Detention (2024)Cruelty Campaign: Solitary Confinement in US Immigration Detention

Transcript Paper: Gearhardt AN, Brownell KD, Brandt AM. From Tobacco to Ultraprocessed Food: How Industry Engineering Fuels the Epidemic of Preventable Disease. Milbank Q. 2026;104(1):0202.https://doi.org/10.1111/1468-0009.70066 https://www.milbank.org/quarterly/articles/from-tobacco-to-ultraprocessed-food-how-industry-engineering-fuels-the-epidemic-of-preventable-disease/ Ashley, let's talk a little bit about, just set the stage for what this paper was all about, and since it was your brainchild, you approached Allan and me about being involved. Tell us what you set out to do and why you thought these issues were worth digging into. Ashley - You know, I've just been so struck that when we think of cigarettes, they were something that's so common, so normal that we kind of think, oh, they've always just sort of been there. But truly, they're just taking a natural plant from the ground and through advancements and corporate engineering and technology and knowhow, they took a poisonous plant and made it into the most deadly and addictive drug in human history. And yet that was, you know, just accompanied by tons of debate. It didn't look like other addictive substances. And I just really felt like, man, we're reliving this history right now when it comes to how we've altered our food supply. I wanted to really bring you all together and see if we could really lay that story out of the, the parallels of these two public health crises. We'll get in a minute into the issue of what you discovered, but tell us what you covered, what the paper was meant to do. Ashley - The paper really goes back from how you take the tobacco plant in the field, or the corn in the field, and walks essentially through all the kind of levers that are being pulled to transform it in very specific ways. And through specific technologies and corporate practices that are being shared by modern cigarettes and ultra processed foods. These products maybe look harmless on their face initially, or don't look like they're just maybe pleasurable or craveable. But truly, I would argue that they've crossed thresholds into things that are addictive and clearly damaging many people's lives. Okay, so several decades ago, I don't know who came up with a term, but there was a lot of discussion about similarities between tobacco industry behavior and food industry behavior. And the press started publishing cover pieces that would say food is the next tobacco. And it was a term that the food industry really didn't like, and they don't want that comparison at all. It'll be interesting to see whether they deserve it. You clearly made that connection in this paper. Allan, let's turn to you. Oh my God. I mean, we could do a 15-hour podcast and not cover the history of the tobacco industry. There's so much to say, enough that you wrote a massive book about it. But give an overall sense, if you will, of the kind of tactics and morality of that industry. Allan - Well, as Ashley already mentioned, early in the 20th Century we wouldn't really be thinking much of cigarettes, and they were just a very peripheral sales consumer item. And over the course of the 20th Century, we came to a point in the middle of the century of the 1970s, and '80s where about half of all American adults were smoking cigarettes regularly. I wanted to understand that. How do you take something that's at the very margin of the economy and culture and make it a dominant consumer force? And I think in that way, we have certain parallels to ultra processed foods. But then there were the questions, how do you make it so popular? Is it dangerous to use? Is it addictive? Does it cause disease? And how do you resist regulation and other public health approaches to try to keep people smoking? And I found a lot of evidence in each of those areas, both of how the industry acted. And when you say, you know, it's ultra processed food like cigarettes, we're learning a lot about ultra processed foods. But we know a ton about what the industry did to make the 20th Century what I call the Cigarette Century. And we have seen really important declines in smoking in the last 30-40 years. It's a remarkable public health effort. But at the same time, the industry worked incredibly hard and, in some ways brilliantly, to maintain the popularity of their product. And underlying all this is the idea that nicotine is highly addictive. And the industry came to understand that certainly before consumers did. And as a result, they could engineer, manage, manipulate the addictive character of a product that kills. I think looking for parallels, both in terms of how the industry did it and how perhaps public health law regulation can undo it, is the critical aspect of what we've been working on together. Okay. So, the tobacco industry did more than just take a plant, dry it out, chop it up, and roll it up in some paper. Then people might be driving whatever natural pleasure there would be from that product. But they did more, didn't they? Allan - Yes. And you talked about nicotine in particular. So how manipulated was this industrial process and was it designed to create such high levels of addiction? Allan - Well, for a long time we couldn't be sure about that. And we have learned that the industry had learned sophisticated techniques of industrial production of cigarettes. So, it wasn't like just chopping up tobacco and putting it in paper. You know, they added many additives. They added liquids. They dried it out, they put it in long strips of tobacco for cutting and packaging. And they had innovated the technologies, instead of human beings rolling cigarettes, they were able through machinery and technology to produce hundreds of thousands of cigarettes a day. And then they had to figure out how do we sell this tremendous volume of cigarettes in order to make our industry truly lucrative. So, there were those aspects. And certainly by the middle of the 20th Century, many people realize that - I smoke regularly and I crave my next cigarette and I'm smoking a pack a day, sometimes two packs a day. And people would ask, well, is it a habit? Is it habituating? Is it addictive? And as the science of addiction really grew in the middle of the 20th Century, we began to realize it had all the characteristics of addiction. But we really didn't know exactly what the companies were doing. And what we did learn in the '80s and '90s is that the companies had a precise ability to manage the nicotine in their product. And they did, so that even as they put filters on and they claimed they had safer cigarettes, they were also producing increasingly addictive cigarettes where we have craving, we have withdrawal, we have tolerance. The basic categories, that structure, how we understand addiction. Okay. We'll dive into some of those in a little more detail, but thanks for that background. Ashley, people kind of get it that drugs can be addictive and they know that alcohol can be addictive. They know that cigarettes can. But what about food? Ashley - Yes, so I think one of the things that when I take a step back, is that the reward and motivation system that alcoholic beverages, cigarettes can start to hijack and drive towards compulsive problematic use, that was laid down in the brain to make sure we were getting enough food. It's really sensitive to food reward, energy density. But the thing is you actually consume nicotine probably most days. Nicotine is actually in a lot of plants like tomato and eggplant, but nobody's getting addicted to the chemical in that delivery vehicle. I would argue the same thing's happening. When we look at our research nobody's getting addicted to minimally processed foods like bananas and broccoli, and salmon filets. It's when you're able to process and titrate and hedonically engineer food reward in a way that mimics the intensity and the sensory appeal and the spikes and crashes and the craveability of something like cigarettes, that you start to see people losing control. And when I read Allan's book, my husband was watching over my shoulder. And he's like, you know, if you highlight every single sentence, it's not gonna help you because you've highlighted the whole book. And reading what Allan laid out about how each wave of cigarette addiction, it wasn't because we suddenly discovered what nicotine was, it's because the industry got better at manipulating engineering, designing, flooding the market with it. And then health washing it, so people didn't really understand what they were getting into. And to me, that is what we've done to our food supply. And the result of that has been the astronomical increases in diet related disease and health concerns. Tell us about the concept of ultra processed food and how that fits in. Ashley - Yes. Yeah, that's a great question. So, ultra processed food is a concept that actually came out at about the same time as the Yale Food Addiction Scale, that Kelly and I published together, about how to operationalize who might be showing signs of addiction and certain foods. Carlos Monteiro from Brazil was noticing that his grocery store was starting to be flooded by foods that you could not make in your home kitchen. I have exactly no idea how to make a double stuffed Oreo or a flaming hot Cheeto, or a Cherry Coca-Cola. And as these products that were industrially created with additives and flavor enhancers that are kind of biologically novel, that's when the disease risk started to go up. And so, these foods are so fundamentally changed in they're kind of most archetypal forms of things, like sodas and, you know, your sweet, savory sort of snacks, that a whole new category had to be created for them. To really distinguish them from, you know, grandma's homemade cookies or, you know, an apple or an orange. Ashley, you're brilliant at framing things. And one of the things that I learned from you a long time ago, and I've used a thousand times in discussions with people, is thinking about food, like turning the coca plant into cocaine and into crack cocaine. That if you take the coca plant into its natural form, people can live in harmony with it. You don't really have addiction. But when you process it and it becomes cocaine, then things change dramatically. And when you hyper process it, like the hyper palatable foods and the ultra processed foods, then the crack cocaine becomes incredibly addictive. So that same sort of phenomenon I think applies here. And it's a very compelling way to think about this. Allan, let's get back to the addiction thing and tobacco. One of the most stunning things I remember about the tobacco history. Is the videotape of the seven tobacco company executives testifying before Congress that nicotine wasn't addictive. Swearing, you know, sworn statements about nicotine. Tell us about that and what that kind of meant in history. Allan - It's a great story and it has a kind of visual linkage to many of us who actually saw those congressional hearings. And it was a brilliant sort of performative politics, if you will. And there had been more and more knowledge that the industry was manipulating nicotine to make cigarettes that they were claiming were safer and not addictive, even more highly addictive. And David Kessler, the head of the FDA under Clinton, had really been a major player in this. And one thing I should say is we were learning more and more about the industry because people were suing them. And they would typically lose the suits, but they would get hundreds, hundreds of thousands of documents. And the industry also had whistleblowers who were coming forward and saying, of course we know it's addictive. So, Henry Waxman, a really fantastic congressman who represented consumers invited all seven of the major tobacco CEOs to a hearing on nicotine. And he went one by one - do you believe nicotine is addictive? And they would say, Congressman, I do not believe that nicotine is addictive. And it's like any great prosecutor, he had figured out how to get them essentially to perjure themselves in front of a congressional, and video news audience. And in fact, the Department of Justice considered for some time whether they should be put on trial and indicted for perjury before Congress. But it was so in congress, with what we had come to know, especially experts, but even, you know, parents and the public and citizens had come to know that it was incredibly difficult to get off of nicotine. It just didn't comport with our existing knowledge. And we're not quite to that point with ultra processed foods yet, but I think we have a good chance to get there because as we understand what they're doing better and we have a sophisticated understanding of the characteristics of addiction, that same question will be put ultimately to CEOs of the food industry. Especially those who are producing these highly addictive products. And there are many people who are involved in this. So, they will tell a story of how we understood we could make our product sell better and be used at a much higher level if we could make it addictive. And regrettably, as we learn more about addictive addiction, we not only learn perhaps how to help people who are addicted. But we often learn how to make certain products even more highly addictive. Ashley, let's take what Allan said and apply it into the food arena. So, if you think about the criteria for addiction, like Allan had mentioned: cravings, withdrawal, and tolerance, and, tolerance being the need to have more of the substance over time in, in order to produce the same pharmacologic effect. How do those things apply to foods? Ashley - Yes. There there's very strong parallels there. And I actually have a paper I wrote with Dr. Alex DiFeliceantonio, where we took the 1988 Surgeon General's report on the addictiveness of tobacco and nicotine in particular. And we took what they identified as the necessary and sufficient criteria to prove that it was addictive. It was a watershed moment for tobacco. And the major one is that people consume it compulsively. Meaning, you know, they want to cut down and they can't. They know it's harming them and they can't. Clearly we see that with ultra processed food. That it shifts mood. It increases pleasure. It reduces negative affect through its mechanism on the brain. And I think if you look at any marketing, you know, they're always saying you're craving meet your maker, get your bliss point. You're not you unless you're eating a Snickers. They show that it was highly reinforced. And that is, you know, animals and humans will work really hard to get access to it. With nicotine one of the major points of that is that animals, about 20% of the time, would work to get nicotine over cocaine. And that was quite striking because cocaine is so powerfully addictive. Well in those same models, animals will work for processed sweet taste and choose it 80% of the time over cocaine. It just shows that when we start altering, processing food reward into these unnaturally intensely stimulating packages, our brains were not evolved to protect itself against that. And then the final pieces that's been kind of added over time has been the cravings. I mean, if you think about what is the core of addiction, it's the craveability of it. That they maximize that. So, you can't stop thinking about anything else. And when I read, and we even quote in our paper, spots where, you know, industries, the big food is having webinars and how to turn cravings into corporate wins. And how to take snackers who are consuming, because their cravings feel unmanageable, but here's how you can keep them snacking even though they want to quit. And so, the craving really seems to me, based on my read of what I've seen from the industry, is the core engine of driving and selling ultra processed food. So, these foods, and I've heard you say this, Ashley, you know, they have less to do with the farm and, you know, these sort of romantic ideas of the farmer growing crops and the crops being harvested and coming to a farmer's market. These are really industrial lab-based, you know, heavy duty factory related products. And there's a real question, isn't there, about what you even should call them food. Ashley - Yes, absolutely. I actually grew up on a farm and I never ate anything that we grew on the farm because it was all due to Ag policy. Just, corn to go into high fructose corn syrup, soy to go into soybean oil. And I was surrounded by what looked like lots of food, but in reality, it was not. And some of the things that I learned in writing this paper with you all is just to what degree ultra processing allows them to even control the molecular structure and size of the different starch chemicals. That carby kind of access point in food. Allan talks in his book about how you can treat tobacco. So, you break it down and make it molecularly more bioavailable so nicotine gets more rapidly into the body. That's a huge driver of addictive potential. I found in ours that they were actually using enzymes that mimic what's in the saliva in your mouth. And hitting starches with it. Essentially you were predigesting, pre salivating, essentially the starch creating what's called a starch slurry. And that's a base of so many common ultra processed foods like cereals and savory snacks. Many of these products really have far more in common with that cigarette and have almost nothing in common, you know, with the apple or the can of beans anymore. You know, that image that you said about pre salivating food. I mean, it's in some ways as if the industry is spitting in your food to bypass your own biological mechanisms that occur when the food gets in the mouth and. People get a kind of a yuck response to that, but it deserves that kind of a response. Let's dive into the paper and talk about what you reported, Ashley. You talk a lot about the kind of processes. You just mentioned one of them, but there are a lot more. What are some of the specific techniques to food processing that surprised you when you started digging in. How did you get this information? Ashley - Yes, so one of the functions that actually didn't surprise me, but it made me look at it in new light, is the work on how we really changed the way we saw cigarettes when we realized they weren't just taking a plant and drying it and rolling it up. But that they were actually curating and titrating these just right doses of nicotine. So, you get stimulated, but not too satisfied and you don't feel overwhelmed by the amount of nicotine. When we realized that was very intentional and designed and titrated, that really changed this from a natural kind of product, it's just a plant to, oh, this is an in industry engineered product. They're controlling so much of this. We all know that they are altering the amount of sweetened refined carbohydrates and fats in our food. I mean, that's just plain knowledge. And at levels that go way beyond what exists in nature. But I think I've become very obsessed with extrusion technology. Extrusion is something where they take really high pressure, high shear mechanical impact, high pH, high temperature. And they can break the corn or the potatoes and things into this slurry that is broken down again into this kind of predigested molecular base that on its own is nasty. No one is like, oh, starch, slurry, yes! They need all the sensory and flavor additives to blitz that and texturize it so it can trick your brain into thinking it's appealing. I realized that actually has such a strong parallel to modern cigarette where, as Allan talks about in his book, one of the major technological advances was creating reconstituted tobacco where they take the tobacco scraps and they do the same sort of process to create what they call a tobacco slurry. That was then very easy to manipulate by putting flavor and preservative additives in it, and that's what makes up a large component of modern cigarette. And so, when we look at these processes and those sensory additives, the flavors, that are put in it, cigarettes have more sugar and flavor additives in them by weight than they do nicotine. And so many of those flavor additives are actually in our ultra processed food supply. Why? Because the flavor and sensory profiles are what you start to become really emotionally attached to. And that starts to drive brand loyalty from a very young age. I could go on and on and on. Oh man, we could be here for a day, so I'm really inhibiting myself. I'll be exhausted. I'll have to go get an ultra processed food from this. But it was stunning to me to see how the goals of the engineering were so shared. And I guess it shouldn't surprise us because, you know, we know that the tobacco companies like Philip Morris and RJ Reynolds actually created, manufactured and sold many of our favorite ultra processed foods that are now in our modern food supply, like Fig Newton's and you know, Hawaiian Punch and things. It really came from the same industrial practices. So Allan, I want to bring this back to the tobacco industry in a minute, but Ashley, I wanted to ask you first. I'm going to make a characterization. Tell me if I'm off on this. The industry is kind of manipulating every possible characteristic of a product. Its fragrance, its color, its texture, everything in the ways you mentioned. It becomes this industrialized product much more than a food. People consume it. They get immense reward from it because it's delivering a drug, basically, to the brain very quickly in a very efficient way. People then, of course, want more of that sensation. If tolerance exists, then it means they need more of the food over time in order to get the same reward. And then you've got a public health nightmare on your hand because people aren't just eating a little bit of these foods, they're eating a lot of these foods. And they're designed in order to produce that very impact. Does that seem fair? Ashley - Absolutely. That sums it up quite nicely. Okay, Allan, back to the tobacco experience. This kind of information that Ashley is talking about in the context of food, and you talked about in the context of tobacco. Manipulation of the product. As this kind of damning information became public knowledge, how did that happen in the tobacco arena? And then what was the consequence? Was it, you mentioned whistleblowers; was it investigative journalism? The hearings you mentioned were important. Scientific research, discovery. It sounds like a whole lot of things happened that made this information available to the public, which in turn changed public opinion against the industry. Allan - Yes, I think that's exactly right. It changed public opinion and it changed public policy and it took a long time. So, these are aspects that I think we have to, you know, acknowledge in thinking about public health and especially these powerful commercial interests that spend a lot of money on lobbying. They spend a lot of money on advertising. They know how to get to kids. These are very challenging. I do think, you know, early in the anti-tobacco campaigns, there were a few lawyers who said, well, we're going to sue them because they have misled, deceived, and in some instances probably acted criminally to build their addictive and extremely harmful life-threatening product. And people said, well, you know, it's everybody's decision whether they want to smoke and people quit all the time, so you're not going to do very well. And I think as a young academic type, I was very skeptical of the suits against the companies. But one thing that happened that I think was unanticipated, the lawyers asked for the company's records and their research reports and what people were doing. And they took depositions and the lawyers often lost the case, but they won an incredible archive that was incredibly self-incriminating of what the industry knew. When they knew it and how they continued to act to sell a harmful product. And I think that began to change things. So once you have documents, you know you're going to be more successful in court. Once you have some documents, you can call the CEOs in and say is it addictive? When they say no, you have documentation to challenge them about their own industry. Obviously, education is important. Investigative journalism. A lot of the documents not only came from the court suits, but from whistleblowers who snuck them out of law firms. Some of the whistleblowers came directly from the industry where they said, here's what my bosses told me. They need to know can you make this cigarette even more addictive? And they knew, for example, that taking nicotine out of cigarettes, which is not that difficult to do given the extent of manipulation, had to be something that was resisted. We could end the tobacco pandemic by just removing nicotine. Even if we did, you know, 10% a year. Many people would be able to stop smoking who cannot. But we had to array a kind of knowledge and practice and advocacy that really hadn't existed till the second half of the 20th Century. Ashley, when Allan mentioned these archives that exist on tobacco industry behavior, there's some food things in there, aren't there? Tell us about that connection between tobacco and food companies. Ashley - Yes, so you know, actually, Dr. Laura Schmidt at University of California - San Francisco, has done this just stunning work by using those same tobacco archives. Because they owned alcoholic beverage and ultra processed food and beverage companies she's been able to show really how much these industries kind of spoke back and forth. The different sectors of Philip Morris and RJ Reynolds, you know, they're big conglomerates. They were pulling scientists working on the cigarettes, or the marketers working on marketing cigarettes to kids, and putting them on and intentionally using that playbook to sell their ultra processed foods and beverages. That's very clear and very intentional. They might not say as blatantly. I feel like they learned their lesson a little bit. Oh, we're going to make this more addictive. They use synonyms even out in the public. Some of it that we report in this paper is not hidden. It's industry trade newsletters. It's interviews on 60 minutes with labor scientists where they're saying, yeah, we design these products, so you get a big flavor burst. And then it fades really rapidly because that makes you want to keep coming back for more and more and more. And yeah, addictive is a good word for that. And so there is this moment where it just becomes so implausible that they don't know that they have crossed the Rubicon into something that is hooking people. That plausible deniability that we're just, you know, giving consumers what they want, not actually engineering their desires to override what they know they should have to nourish themselves. It just feels beyond the pale to me to believe that's the case. Allan, look, you mentioned delay. And I'd like to talk about that a little bit more. There's a point in time when the science on something becomes robust. And you're very certain say that tobacco is causing lung cancer and heart disease.  And then you can't change things the next day or the next week. So, a little bit of delay is probably acceptable and to be understood. But the delay in this case between that knowledge and significant public health action policy action wasn't measured in days, weeks, months, or even years. It was decades. And you can count the number of attributable deaths to that delay in the millions. What did the industry do to make that delay as long as possible in terms of planting doubt, conflicts of interest with science and things like that? Allan - This is highly relevant to our moment because I make a few claims in the book. One is that the industry invented disinformation and misinformation. And there's always this way that says, well, I know that study appeared, but we need more information. And this was very clever on the part of the tobacco companies because they said, well, you know, that science shows this, but that science is unreliable. And we need to use different methods. And lung cancer is not a result of cigarette smoking, it's actually genetic. And maybe there are a few people that shouldn't be smoking cigarettes. We should be able to identify what's different about them. They kept finding strategies of delay, manipulation, building uncertainty. There's one of the tobacco documents in this phase that says, from now on, our product is doubt. And what they really needed to do to sell the product was to create doubt about a science that was highly robust and really important to consumers. On the other hand, I think consumers are sensitive to being manipulated. They don't like that. They don't like being tricked. They know these industries, especially tobacco industry, you know, is disreputable. And as that became the case, what did they know and what are they selling. We began to see some slow shifts in public awareness. And, you know, it's so interesting presenting the cigarette problem to a jury in 1970 became radically different than presenting the case against the tobacco companies in the 1990s. And a lot had changed, A lot had been documented and, you know, we never even thought of the idea that a company would scientifically mislead us probably until in any consequential way till the middle of the 20th Century. And now we're incredibly skeptical and I think taking advantage of the public skepticism, both politically and culturally is going to be one of the important issues of pushing back against what I've called rogue industries. They're operating unethically; in many cases, unlawfully. They're misrepresenting what they produce. And they have the idea that having addicted customers is the best customer. And Warren Buffet once said, you know the tobacco industry, that's crazy. It cost a dime to make it. You sell it for a dollar and its addictive. He said, what industry could be more, you know, lucrative than tobacco? Ashley, how do those things apply into the food area now? Ashley - Oh, my brain is just exploding with all the things I want to say. But I think I have an answer to Warren Buffett, which is if you've pulled all those same levers and pretend to people that it's food, and it's because we all have to eat, you know? And I walk around a grocery store and I, in my head, I'm like, if I waved a magic wand, and all the products in here that are masquerading as food but are actually ultra processed, chemically adulterated starch, slurries essentially disappeared. There is so little food in my grocery store. Real food. And it's also expensive. We would be rioting in the streets if we really saw the degree that we're not being adequately nourished or supported in our current environment. And it's the mirage of abundance that is totally hooking us. You know, taking us hook, line, and sinker. And so, you know, I'll have people often say to me, you know, it's food. Like can't really be addictive. We all need to eat. And to me that is absolutely true. Just like we all need pain management. And there used to be a belief, a myth, that if you were in pain, you couldn't get addicted to painkillers like opiates which we now know is incredibly wrong. That just because we need calories to survive doesn't mean that if you manipulate and hedonically engineer those products, that it won't impact the brain in a way that can drive it in compulsive problematic ways. It's so essential for us to carve out, yes, you need real nourishing food. This is real nourishing food and these other things. I'd love it if the grocery store, it's like you're walking around this spot, you know you're getting real food. Sure, you want to go get those Cheetos, go for it. But it's in a very clear designated area that you're not being tricked into thinking that you're eating something that's nourishing you when it's really addicting you. So, people have very strong affective attachments to foods. Particular foods that they like. Some of it is kind of what you grew up with, what your parents gave you, but a lot of it's marketing as well. And you mentioned a Cheeto or Coca-Cola, or a Dorito or a Twinkie or whatever it is. People don't want that taken away from them. Tell me if this is correct, the problem isn't so much that people eat Cheetos. It's that they overeat Cheetos, and then you add to that all the other thing, not just that food. But then you've got a real problem. Could it be a matter of just removing some of the especially troublesome ingredients from that. If you look at the list of ingredients on these foods, there could be 25 or 30 different ingredients. Well, what if, what if 12 of them got taken out or 13 or 15 of them got taken out? You'd still have the food; it would still have its taste. People could enjoy it, but it's not hijacking your biology. Ashley - Yes, I'm very skeptical of that as the response, because as Allan lays out in his book, we were like, okay, if we just get the tar out of the cigarette. You know, it's all fine, Vapes, right? Oh, you're vaping. It's fine. It will be harmless because our reward system is so porous to different levers that signal food reward. We see it with the non-sugar sweeteners. Look, we took all the sugar out, we gave you Diet Coke, we gave you non-sugar sweeteners. It's a get out of jail free card. And now we're realizing how much that messes up our gut microbiome, could potentially lead to earlier brain aging and so, you know, abstinence, clearly making this stuff illegal, that's never the goal. But I think that sense of saying, oh, we can just engineer our way out of this is unlikely. And we have the alternative. You know, for what should be the majority of what we're eating. I love a Reese's Cup, right? I will have an ultra processed food, but it shouldn't be 60% of the food supply, or 70% of what my kids are getting for their calories. And so again, that clear understanding that this is something that's fundamentally different from the food that nourishes us. We have the answer which is real food. If we poured even a tiny amount of the investment, even closing the tax loopholes on things like ultra processed food marketing to kids that they get tax breaks on and invested that into technology to make real food in its original food matrix affordable, accessible, convenient. That stuff is tasty. Have a fresh apple. It's just everything's been wired for that to be the minority of our food supply. That's often unaffordable and we all feel really time poor. These are solvable problems. We've just been shoving all our money towards how we make new flavor additives to sell high fructose corn syrup, starch, slurries. So, we just need to have the right in incentives in mind. Your point is very well taken that government trying to say, okay, let take out this ingredient or that ingredient is stepping into a trap. It makes all the sense to me in the world that that is a trap because. Using that philosophy requires a trust in the industry that if you ask them to take out these 12 things, they're not going to put in 12 new things that might even make things worse. And both of these industries, tobacco and the food industry have done everything but earn our trust so that's a very good cautionary note that you raised. I would say in the tobacco area, the idea of that we think that, you know, vaping will be harm reduction. And there's been a strong political notion that we should be, you know, doing harm reduction. And of course, in many instances, harm reduction can be helpful. But I found in tobacco, that I can't trust the industry to make a harm reduction product that's not going to get kids addicted. That's going to, you know, make sure that we're not using both tobacco and nicotine in the form of vape or other products. And so while many people who I admire in the public health world have said, yes, harm reduction is the way to go. I don't think that's true with tobacco. We have a lot of children and adolescents today who are profoundly addicted to nicotine. So, this discussion has led to lots of, oh my God, kind of observations from both of you. Paints a pretty scary picture of the food supply. How much manipulation there is. And how much harm gets caused by it. I'm hoping we might end on a bit of a positive note if there is one here. I'd like to ask each of you, is there a reason to be hopeful about the future? Allan, let me start with you. You're looking in on this with a unique perspective because of your years and years of working on tobacco. As you look in on the food space and see what's happening, what do you think? Allan - Well, I tend to be an optimist. I believe public policies can make a difference. I believe the courts can be used to serve consumers who have been harmed in the market. So, I have seen those things work to a really significant degree around the cigarette. Especially in countries where we have resources for education, where we can make policies that sometimes work or mostly work. I don't think I ever would've thought when I started this work in like the 1980s that we would've gotten so far. I once said to my son when he was seven, he was taking a flight with me. And I said, you know, people used to smoke on airplanes. And he said, no, that's impossible. And he just couldn't believe the idea that we had let people smoke on airplanes. And I've been collecting cigarette packages that were given out by the big airlines. Of course, you and I, Kelly, remember probably, when they start to put smokers in the back of the plane. But the smoke was wafting throughout it. And a lot of things that seem almost impossible now, were actually reduced through regulation and politics and public health. I'm very hopeful that we can use what we've learned about how to get smoking from 50% of the population down to 15 or 12, as bad as that is. And apply it to other gigantic risks like ultra processed foods. All right, thanks for that positive note. Ashley, what do you think are there grounds for being positive? Ashley - Yes, I'm also a huge optimist. I feel wildly optimistic. I just, from listening to consumer sentiment right now, the degree to which corporations are able to hack our limbic systems, I mean, you see it right now with social media and sports betting. I think in our bones as a society, we're starting to just get fed up. And to me there is nothing that is more clear cut of how industries can manipulate us than taking food, the thing we most evolved to care about and to find rewarding and nourishing, and somehow jacking it up into an addictive, harmful substance. And I have two little kids. I have a five and 7-year-old and I am just as a mom full of rage every time I go grocery shopping because they've just shoved protein in a Pop-Tart, now they're trying to tell me it's a health food. I think we're catching onto them, and I think that there is no way to go but up. And again, we already have the solution. In opiates, we are still struggling to find non-addictive pain management. We have non-addictive food and it's called, you know, minimally processed real foods. So, it's just about putting the incentives in the right place. BIOS Ashley Gearhardt, Ph.D., is a Professor of Psychology in the Clinical Science area at the University of Michigan. She also earned her B.A. in psychology from The University of Michigan as an undergraduate. While working on her doctorate in clinical psychology at Yale University, Dr. Gearhardt became interested in the possibility that certain foods may be capable of triggering an addictive process. To explore this further, she developed the Yale Food Addiction Scale (YFAS) to operationalize addictive eating behaviors, which has been linked with more frequent binge eating episodes, an increased prevalence of obesity and patterns of neural activation implicated in other addictive behaviors. It has been cited over 800 times and translated into over ten foreign languages. Her areas of research also include investigating how food advertising activates reward systems to drive eating behavior and the development of food preferences and eating patterns in infants. She has published over 100 academic publications and her research has been featured on media outlets, such as ABC News, Good Morning America, the Today Show, the Wall Street Journal, and NPR. Allan M. Brandt is the Amalie Moses Kass Professor of the History of Medicine and Professor of the History of Science at Harvard University, where he holds a joint appointment between the Faculty of Arts and Sciences and Harvard Medical School.  Brandt served as Dean of the Graduate School of Arts and Sciences from 2008 to 2012.  He earned his undergraduate degree at Brandeis University and a Ph.D. in American History from Columbia University.  His work focuses on social and ethical aspects of health, disease, medical practices, and global health in the twentieth century.  Brandt is the author of No Magic Bullet:  A Social History of Venereal Disease in the United States since 1880 (paperback, 1987; 35th Anniversary Edition, 2020); and co-editor of Morality and Health (1997).  He has written on the social history of epidemic disease, the history of public health and health policy, and the history of human experimentation, among other topics.  His book on the social and cultural history of cigarette smoking in the U.S., The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product that Defined America, was published by Basic Books in 2007 (paperback, 2009).  It received the Bancroft Prize from Columbia University in 2008 and the Welch Medal from the American Association for the History of Medicine in 2011, among other awards.   Brandt has been elected to the National Academy of Medicine and the American Academy of Arts and Sciences.  In 2015, he was awarded the Everett Mendelsohn Excellence in Mentoring Award by the Harvard Graduate School of Arts and Sciences.  In 2019-20, Brandt was a recipient of fellowships from the American Council of Learned Societies and the Radcliffe Institute for Advanced Study.  He recently served as the interim chair of the Department of Global Health and Social Medicine at Harvard Medical School.  Brandt is currently writing about the history and ethics of stigma and its impact on patients and health outcomes.  

It's hardly a secret that Canada has a housing problem. Usually it's described by the affordability issues around owning a home, but there is another and arguably more pernicious problem. Too many Canadians simply don't have one. Treating housing as a human right is one way to start facing that second housing crisis. Host Amanda Lang talks with Pearl Eliades, a Quebec-based lawyer specializing in human rights and a professor at the Max Bell School of Public Policy, and Dr. Andrew Boozary, founding executive director of the Gattuso Center for Social Medicine at the University Health Network in Toronto.

We are told that our personal health is our individual responsibility based on our own choices. Yet, the biological truth is that human health is dependent upon the health of nature's ecosystems and our social structures. Decisions that negatively affect these larger systems and eventually affect us are made without our consent as citizens and, often, without our knowledge. Dr. Rupa Marya, former Associate Professor of Medicine at UC San Francisco, and co-founder of the Do No Harm Coalition, says “social medicine” means dismantling harmful social structures that directly lead to poor health outcomes, and building new structures that promote health and healing. This is an episode of the Bioneers: Revolution from the Heart of Nature series. Visit the ⁠radio and podcast homepage⁠ to learn more.

Canadians are waiting way too long in emergency rooms. Dr. Andrew Boozary, executive director at the Gattuso Centre for Social Medicine at Toronto's University Health Network and founder of Dunn House, explains how they've cut ER visits by 52% and length of stays by 79% (5:15) in our feature interview presented by Mercedes-Benz Edmonton West.  Stick around for former Jason Kenney staffer Blaise Boehmer's behind-the-scenes story (42:00) of the then-Alberta premier introducing recall legislation (and why Blaise thought it was a mistake from the start).  THIS EPISODE IS PRESENTED BY HANSEN DISTILLERY -- EDMONTON'S ORIGINAL DISTILLERY -- ROOTED IN PRAIRIE GRIT AND A REBELLIOUS SPIRIT. PROUDLY LOCAL, ALWAYS ORIGINAL. HANSEN DISTILLERY IS MADE RIGHT, RIGHT HERE. https://hansendistillery.com/ MBEW: https://www.mercedes-benz-edmontonwest.ca/ MORE on DUNN HOUSE: https://www.toronto.ca/community-people/housing-shelter/building-affordable-homes/housing-initiatives/supportive-housing-developments/90-dunn-ave/ CHECK OUT OUR INTERVIEW on BRIDGE HEALING at the ROYAL ALEX: https://rtrj.info/112825Bridge 1:17:00 | Are you an audiophile? Are you looking for the best bang-for-buck headphones on the market? Real Talker MetaModern tees up an interesting conversation. ($60,000 for headphones?!) 1:32:00 | Jespo and Johnny dip into the Real Talk Live Chat powered by Park Power to hear Cassandra's story of living on the edge of homelessness.  SHARE YOUR STORY: talk@ryanjespersen.com  FOLLOW US ON TIKTOK, X, INSTAGRAM, and LINKEDIN: @realtalkrj & @ryanjespersen  JOIN US ON FACEBOOK: @ryanjespersen  REAL TALK MERCH: https://ryanjespersen.com/merch RECEIVE EXCLUSIVE PERKS - BECOME A REAL TALK PATRON: patreon.com/ryanjespersen THANK YOU FOR SUPPORTING OUR SPONSORS! https://ryanjespersen.com/sponsors The views and opinions expressed in this show are those of the host and guests and do not necessarily reflect the position of Relay Communications Group Inc. or any affiliates.

In this episode of PRIM&R's podcast, "Research Ethics Reimagined," we explore the unprecedented wave of federally funded research terminations affecting tens of thousands of study participants. Brandon Brown, MPH, PhD, is a Professor of Medicine at UC Riverside School of Medicine's Department of Social Medicine, Population and Public Health and a Hastings Center Fellow. Dr. Brown discusses the ethical and practical challenges researchers and IRBs face when studies end suddenly due to funding cuts. He examines how IRBs and researchers can collaborate to develop guidance to ensure communication and transparency for impacted researchers and participants.

Send us a textDr. Neal Baer, MD ( https://en.wikipedia.org/wiki/Neal_Baer ) is an award-winning showrunner, television writer/producer, physician, author, and a public health advocate and expert.Dr. Baer lectures on Global Health and Social Medicine and is the Co-Director of the master's degree program in Media, Medicine, and Health at Harvard Medical School ( https://ghsm.hms.harvard.edu/faculty-staff/neal-baer ). Previously, Dr. Baer was Clinical Professor of Preventive Medicine at the Keck School of Medicine at the University of Southern California and an Adjunct Professor in the Department of Community Health at the Fielding School of Public Health at UCLA where he established the Global Media Center for Social Impact using new media to promote global health.Dr. Baer  was an Executive Producer and showrunner for Designated Survivor, Under the Dome, Law & Order: Special Victims Unit, and a writer and producer on ER ( https://www.imdb.com/name/nm0046371/ ). Dr. Baer is an accomplished author with both fictional novels, including Kill Switch and Kill Again, and non-fiction titles, including The Promise and Peril of CRISPR ( https://www.amazon.com/Promise-Peril-CRISPR-Neal-Baer/dp/1421449307 ), a timely collection of essays on the pressing possibilities and risks of gene-editing technology, available at major booksellers.Dr. Baer graduated from Harvard Medical School and completed his internship in Pediatrics at Children's Hospital, Los Angeles. He received the Jerry L. Pettis Memorial Scholarship from the American Medical Association as the most outstanding medical student who has contributed to promoting a better understanding of medicine in the media.  The American Association for the Advancement of Science selected him as a Mass Media Fellow.#NealBaer #HarvardMedicalSchool #CRISPR #GeneEditing #Pediatrics #DesignatedSurvivor #UnderTheDome #LawAndOrderSpecialVictimsUnit #ER #SocialImpact #PublicHealth #GlobalHealth #JenniferDoudna #EmmanuelleCharpentier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

Artist Shelley Bruce is a 4th generation, Black Los Angelino, sharing her service work with a focus on the arts, healing and activism. With two Bachelors in Ethnic Studies and Fine Art, for nearly 20 years, Shelley has performed poetry at hundreds of shows, directed nonprofit organizations, and organized social justice programs throughout Southern California. She has most notably traveled to Washington DC, New York, Ghana, London, Barcelona, and across Southern California sharing her artistic expression. Her first book of poetry titled On Blooming (2018) first poetry album Heaven Here (2021), and newest poetry EP “MVP.iii” (2024) reflect some of her published bodies of work. Shelley is also the founder of grassroots movements Day of Healing and BIPOC cultural production company The Heart Dept. Her central focus is to create wellbeing for all people through compassion-centered, sustainable movements.theheartdept.cowww.instagram.com/artistshelleybruce

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Kevin: Being able to build real relationships.The link between unresolved trauma and recidivism is undeniable. In this episode of Superpowers for Good, guest Kevin Shird shared a profound perspective on how mental health challenges contribute to poor decision-making and the cycle of incarceration. Kevin, a professor, author, and advocate, is no stranger to the justice system, having experienced it firsthand. Now, he's using his story to create a roadmap for change.Kevin explained that unresolved trauma often plays a central role in the repetitive cycles of poor choices many individuals make post-incarceration. “Poor choices are actually tied to unresolved trauma,” he stated, adding, “when trauma is unresolved, there's a propensity for continuing this hamster wheel of just poor choices after poor choices.” His insights shed light on a key issue: the need for better mental health care within prisons to address these deeply rooted issues before individuals reenter society.Kevin shared the heartbreaking story of a friend he met while incarcerated—a man who initially served a short sentence but, after his release, committed a double murder and now faces life in prison. The tragedy, Kevin emphasized, could have been prevented with better mental health support during his friend's incarceration. “Hurt people hurt people,” Kevin explained. “When people aren't well... sometimes their struggles land in our laps.”Kevin advocates for placing licensed clinical social workers inside prisons as a proactive solution. He pointed out that 95% of incarcerated individuals will eventually return to society, becoming our neighbors, coworkers, and community members. By providing mental health support behind prison walls, he believes we can reduce recidivism, enhance public safety, and foster healthier communities.This episode reinforced the urgent need for systemic reform to prioritize mental health care in the criminal justice system. Kevin's work, including his book A Life for a Life, serves as both a call to action and a source of hope. Through his advocacy, he's demonstrating how addressing trauma can transform lives and break cycles of harm.By highlighting these issues, Kevin reminded us that change is possible—and it starts with seeing the humanity in everyone.tl;dr:Kevin Shird shares how unresolved trauma drives recidivism and advocates for better mental health care.He highlights the importance of placing licensed social workers in prisons to support incarcerated individuals.Kevin recounts a tragic story to illustrate how unaddressed trauma leads to devastating consequences.He explains his superpower of authentic connection and how storytelling fosters healing and understanding.Kevin encourages vulnerability to build deeper relationships and drive meaningful change in the world.How to Develop Authentic Connection As a SuperpowerKevin Shird's superpower lies in his ability to authentically connect with people through storytelling. “I pride myself on just being able to build real relationships,” Kevin explained. He emphasized the importance of “removing the mask” to connect with others on a deeper, human level. By sharing his vulnerabilities and personal experiences, Kevin creates bonds that inspire healing and understanding. “Everybody has a story,” he said, reminding us that even when our struggles differ, they are all significant and worthy of empathy.Kevin recounted how sharing a vulnerable story about his father's alcoholism in his first book led to powerful connections with readers. Despite initial embarrassment, he wrote about his father's addiction, and the response was overwhelming. Readers reached out to share their own experiences with addicted family members, often in tears. This demonstrated how his authenticity in storytelling inspired others to confront and heal from their own struggles.Tips for Developing Authentic Connection:Remove the emotional “mask” and embrace vulnerability.Recognize that everyone has a story, even if it differs from yours.Focus on building genuine human connections by listening and empathizing.Use storytelling to create shared experiences and inspire others.By following Kevin's example and advice, you can make authentic connection a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileKevin Shird (he/him):Author and writer, Kevin Shird Enterprises About Kevin Shird Enterprises : Content CreationWebsite: a.co/d/9peNrrsX/Twitter Handle: @kevin_shirdCompany Facebook Page: facebook.com/KevinA.ShirdOther URL: simonandschuster.com/books/A-Life-for-a-Life/Kevin-Shird/9798888458440Biographical Information: Kevin Shird is a four-time published author, activist, and screenwriter. He has become an expert on using the past to build a better future. Shird began his very unorthodox journey at the tender age of sixteen when he started dealing drugs on the streets of Baltimore. This led to him serving a total of almost twelve years in prison. Since leaving prison, Shird has monetized his life's lessons by authoring books on social issues. He lectures at colleges and universities across America on issues like education, public health policy, and mass incarceration. During the Obama Administration, he collaborated with the White House and President Obama's Clemency Initiative. In 2018, he became an associate at Johns Hopkins University's Center for Medical Humanities and Social Medicine, where he co-teaches a class on public health. Today, he serves as a professor at Coppin State University. Linkedin: linkedin.com/in/kevin-shird-6b76455aInstagram Handle: @kevin_shirdSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, DealMaker, DNA, Rancho Affordable Housing (Proactive). Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear |  Matthew Mead, Hempitecture |  Michael Pratt, Qnetic | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on July 15, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, July 16, 2025, at 1:00 PM Eastern. Devin Thorpe, CEO and Founder of The Super Crowd, Inc., will lead a session on "Balance Sheets & Beyond: The Impact Investor's Guide to Financials." If terms like “income statement” and “cash flow” make your eyes glaze over, this session is for you. Devin will break down the fundamentals of financial statements in clear, simple language—perfect for beginners who want to better understand the numbers behind the businesses they support. Whether you're a new investor, a founder navigating financials, or simply curious about how money moves through mission-driven companies, you'll leave this session more confident and informed. Don't miss it!SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Apply for the Live Pitch here. VIPs get access to our better-than-in-person networking, including backstage passes, VIP networking and an exclusive VIP webinar! Get your VIP access for just $25. A select group of affordable sponsorship opportunities is still available. Learn more here.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Devin Thorpe is featured in a free virtual masterclass series hosted by Irina Portnova titled Break Free, Elevate Your Money Mindset & Call In Overflow, focused on transforming your relationship with money through personal stories and practical insights. June 8-21, 2025.Join Dorian Dickinson, founder & CEO of FundingHope, for Startup.com's monthly crowdfunding workshop, where he'll dive into strategies for successfully raising capital through investment crowdfunding. June 24 at noon Eastern.Future Forward Summit: San Francisco, Wednesday, June 25 · 3:30 - 8:30 pm PDT.Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Impact Accelerator Summit is a live in-person event taking place in Austin, Texas, from October 23–25, 2025. This exclusive gathering brings together 100 heart-centered, conscious entrepreneurs generating $1M+ in revenue with 20–30 family offices and venture funds actively seeking to invest in world-changing businesses. Referred by Michael Dash, participants can expect an inspiring, high-impact experience focused on capital connection, growth, and global impact.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Resources for the Community___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials United States Patent & Trademark Office Website and Email https://www.uspto.gov/usptoinfo@uspto.govi-MAK Websitehttps://www.i-mak.org/i-MAK Briefs & Reports https://www.i-mak.org/resource-type/briefs/______________________________________________________________________Tahir Amin, founder of I-MAK, joins us to break down why GLP-1 meds like Ozempic and Mounjaro stay so pricey. We dig into evergreening, patent thickets, and how pharma companies use legal loopholes to delay generics and extend monopolies.We also explore why some companies spend more on stock buybacks than drug innovation—and what that means for access. If you've felt exploited by the system, you're not alone. But there's hope. Learn about the policy changes ahead and how you can take action to fight for affordable meds.Tahir Amin bio:Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address the systemic inequities in how medicines are developed and distributed. He has over 30 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. His work focuses on changing the structural power dynamics that allow health and economic inequities to persist by challenging and re-shaping IP laws and the related global political economy to better serve the public interest.  He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and has served as legal advisor/consultant to many international groups, including the European Patent Office and World Health Organization, as well as testifying before the U.S. Congress on intellectual property and unsustainable drug prices.Special Guest Co-Host, Amanda Bonello from GLP-1 Collective https://glp1collective.org/ _______________________________Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

In this episode of I Thought You'd Like to Know This, Too, ITEST presents a webinarentitled  "Bioethics & AI as Human Flourishing: Where Catholic & Orthodox Social Teaching meet in One Christian Social Ethos" (June 14, 2025)Dr. Constantine PsimopoulosBIOETHICS AND AI AS HUMAN FLOURISHING: WHERE CATHOLICS AND ORTHODOX MEET IN ONE CHRISTIAN SOCIAL ETHOSConstantine Psimopoulos is a Professor (Adj.) of Bioethics at Hellenic College Holy Cross Greek Orthodox School of Theology, teaching Christian Ethics and Social Ministries and is on the faculty at Harvard's Initiative on Health, Spirituality and Religion, of which he is also Senior Program Administrator, and the Human Flourishing program. He has another Academic research appointment in Global Health and Social Medicine and the Center for Bioethics at Harvard Medical School. At Harvard, he co-teaches the course Religion and Public Health and a new required module taught to all MD/PhD students. Constantine serves as the Director of the Division of Bioethics of the Orthodox Academy of Crete (Ecumenical Patriarchate), and as an Invited Member to the Inaugural National Committee on AI – Artificial Intelligence (and Theology) of the Greek Orthodox Archdiocese of America.AbstractThis presentation draws a comparison between Catholic social teaching and the Social ethos of the Orthodox church. Both traditions have some parallels in the way they approach AI, from a bioethical perspective that addresses social justice. The document ‘For the Life of the World' (F.L.O.W.) of our Ecumenical Patriarchate of Constantinople, emphasizes that science and technology are a wonderful product of a God-given human creativity, and that “the desire for scientific knowledge flows from the same wellspring as faith's longing to enter ever more deeply into the mystery of God.” It is an imperative to use AI for Human Flourishing. From a Christian bioethical lens, science and technology, and in particular Artificial Intelligence (AI), can serve as one concrete example of how this can be addressed.Fr. Michael Baggot, LCProgramming with Purpose: Guiding AI through Catholic Social TeachingFr. Michael Baggot is Legionary of Christ, an Associate Professor of Bioethics at the Pontifical Athenaeum Regina Apostolorum, and an Invited Professor of Theology at the Pontifical University of St. Thomas Aquinas (the Angelicum) and the Catholic Institute of Technology (CatholicTech). He also serves as a professor for the Joint Diploma in Leadership: Service through Virtues and the Catholic Worldview Fellowship summer program. In addition, Fr. Michael is a Research Scholar at the UNESCO Chair in Bioethics and Human Rights and a member of the Scholarly Advisory Board for Magisterium AI. He is also a fellow of the Fr. James L. Heft, SM Generations in Dialogue program at the Institute for Advanced Catholic Studies at the University of Southern California.AbstractAs an expert in humanity, the Catholic Church is deeply interested in the AI technologies that are shaping family life, education, medicine, religious practice, and other key aspects of social life. The presentation draws on the social doctrine of the Catholic Church to highlight the virtues and social structures most conducive to using AI tools to promote human flourishing. It gives special attention to the influence of AI companion systems on the loneliness epidemic and the quest for social connections. The conference also examines the significance of ecumenical dialogue, interreligious dialogue, and dialogue with secular traditions in addressing the perennial philosophical questions that emerging technologies raise.Bioethics and AI as Human Flourishing: Where Catholic and Orthodox Social Teaching meet in One Christian Social Ethos - Institute for Theological Encounter with Science and Technology

In this poignant and powerful final episode of The Gritty Nurse Podcast, we close this chapter with a truly essential conversation. We are honoured to welcome former Minister Mark Holland, who offers an exclusive look into the federal government's pivotal efforts to improve Canadian healthcare. From the pressing issue of Pharmacare to strategies for a healthier nation, Minister Holland addresses what's being done on a federal level to make a tangible difference in the lives of Canadians. Amie & Sara dive deep into the critical issues that define our healthcare landscape. We discuss the pervasive problem of healthcare silos across Canada and the urgent need to address health misinformation and improve health literacy. We bring into sharp focus the national nursing shortage, exploring how the government plans to integrate and rely on nursing to fortify primary care. Finally, we raise a crucial concern about protecting Canada's borders from potential health threats, particularly in light of recent public health challenges in the US. Join us for this unmissable episode as we reflect on the journey of The Gritty Nurse, celebrate the grit of healthcare professionals, and look towards a healthier future for all Canadians. Thank you for being a part of our community. Mark Holland Bio: The Honourable Mark Holland was first elected as the Member of Parliament for Ajax in 2004, serving until 2011, and was re-elected in 2015, 2019, and 2021. A lifelong resident of the Ajax-Pickering area, Minister Holland has served his community for over 20 years. Before entering federal politics, he was elected as a Durham Regional Councillor, serving from 1997 to 2004. As a Member of Parliament, Minister Holland has served in many roles including as the Leader of the Government in the House of Commons, and as Chief Government Whip. He has been a staunch advocate of marriage equality rights, and played a key role in helping to reform Canada's animal cruelty laws. In both public and private roles, Minister Holland has backed health-related initiatives, serving as Executive Director of the Heart and Stroke Foundation of Canada's Ontario Mission, as well as its National Director of Children and Youth. As Minister of Health, Minister Holland has worked to sign bilateral health care funding agreements with provinces and territories to improve health care across the country, launched the Canadian Dental Care Plan that will help up to 9 million Canadians get the essential dental care they need, and recently has introduced pharmacare legislation that will provide universal access to contraception and diabetes medications. Social Media Links: Mark Holland (@markhollandlib) • Instagram photos and videos https://x.com/markhollandlib?s=21   Thank You to Our Gritty Nurse Community As we close this final chapter, we want to extend our deepest gratitude to everyone who has been a part of The Gritty Nurse journey. To our loyal listeners, your unwavering support and engagement have fueled every episode. To our incredible friends, guests, and guest co-hosts, thank you for sharing your invaluable insights, stories, and expertise—you've enriched every conversation and truly made this podcast what it is. We also want to acknowledge the media for amplifying our voice and helping us reach a wider audience. And to everyone who has cheered us on, shared an episode, or simply been along for the ride, your belief in our mission has meant the world. It has been an honour and a privilege to connect with you all, and we are profoundly grateful for every moment of this incredible journey. Sincerely, With GRIT and Gratitude Amie & Sara Order our Book, The Wisdom Of Nurses! Leave us a review on Amazon! https://www.harpercollins.ca/9781443468718/the-wisdom-of-nurses/  https://www.grittynurse.com/ YouTube: https://www.youtube.com/@grittynursepodcast  Facebook: https://www.facebook.com/grittynurse Instagram: https://www.instagram.com/gritty.nurse.podcast/ X: https://x.com/GrittyNurse  LinkedIn: https://www.linkedin.com/company/grittynurse  

This week on The Gritty Nurse Podcast, we're diving deep into a topic that's should not be considered revolutionary--but is fundamentally human and morally ethical: the idea that a safe, stable and affordable housing should be considered a prescription for health. Medicine is not just about pills and procedures – it is about examining and dealing with humans and their entire situations. We discuss the profound impact of social medicine and how addressing the root causes of illness, like housing insecurity, can transform individual well-being and public health and improve healthcare outcomes overall. Joining us this week is Dr. Andrew Boozary, a leading voice in healthcare advocacy and social medicine. Dr. Boozary will unpack the compelling evidence linking housing to health outcomes, from chronic disease management to mental wellness. We'll explore innovative programs where housing is being integrated into healthcare solutions, and challenge the traditional boundaries of what it means to truly care for a patient. Tune in as we discuss: The core principles of social medicine and why it's gaining traction in healthcare. The state of homelessness in our in the GTA and how current trends reflect broader issues. How homelessness is a profound health crisis,and the economic impact it has. The biggest challenges to achieving truly equitable housing for all. Why housing is fundamentally a human right, and what that truly means for policy and practice. Inspiring wins and success stories, like the impactful work of Dunn House, demonstrating what's possible when we prioritize housing. Practical actions the average person can take to support those who are unhoused in their communities. Get ready for a thought-provoking conversation that will make you rethink the very definition of healthcare and the essential role of social determinants in fostering a healthier society. More about Dr. Boozary Dr. Andrew Boozary is a primary care physician, policy practitioner, researcher, and founding executive director of the Gattuso Centre for Social Medicine at the University Health Network. As the driving force behind Dunn House, Canada's first social medicine housing initiative, he has been a leader in integrating health care and housing to address the social determinants of health. His work focuses on advancing health equity and improving outcomes for underserved populations. Dr. Boozary completed his medical training at the University of Toronto and health policy training at Princeton and Harvard. He has served in senior advisory roles for policymakers at various levels of government, shaping public policy on primary care reform and pharmacare. He is also the founding Editor-in-Chief of the Harvard Public Health Review and holds the Dalla Lana Professorship in Policy Innovation at the University of Toronto. Recognized for his impact in health equity and social justice, Dr. Boozary is a Clarkson Laureate for Public Service and the youngest physician to receive the Louise Lemieux-Charles Health System Leadership Award. In 2024, Toronto Life named him one of the city's most influential people. His writing and analysis appear in high-impact academic journals and major media outlets, and he was the youngest Convocation speaker for the Temerty Faculty of Medicine at the University of Toronto. Order our Book, The Wisdom Of Nurses! Leave us a review on Amazon! https://www.harpercollins.ca/9781443468718/the-wisdom-of-nurses/ https://www.grittynurse.com/ YouTube: https://www.youtube.com/@grittynursepodcast Facebook: https://www.facebook.com/grittynurse Instagram: https://www.instagram.com/gritty.nurse.podcast/ X: https://x.com/GrittyNurse LinkedIn: https://www.linkedin.com/company/grittynurse

Send us a textHealthcare isn't just something that happens in hospitals—it's happening in our homes, whether we realize it or not. But what if home wasn't just a backdrop for health, but an active partner in healing?In this episode, Dr. Andrew Boozary—Founding Executive Director of University Health Network's Gattuso Centre for Social Medicine—discusses the Dunn House project, a first-of-its-kind initiative where a hospital campus is prescribing permanent housing as part of patient care. Because without a stable home, how can someone truly get better? Meanwhile, Dr. Upali Nanda, EVP and Global Sector Director of Innovation at HKS, shares how her team is using VR to immerse designers in the lived experiences of real patients, revealing the unseen barriers to health inside the home.Together, we'll explore how housing, healthcare, and design are colliding in ways that could reshape the built environment—and why it's time for designers across all disciplines to start thinking about home in a whole new way.HKS Home as Health Hub Idea LabDunn House Social Medicine Project  

Welcome to the Personal Development Trailblazers Podcast! In today's episode, we'll break down the science of decision-making to help you escape burnout and design a career you loveMark Shrime is an internationally renowned speaker, surgeon, author, coach, and cat dad. He serves as the Editor-in-Chief of BMJ Global Health and a Lecturer in Global Health and Social Medicine at Harvard Medical School.Previously, he was the International Chief Medical Officer at Mercy Ships, the founding O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, and the Director of the Center for Global Surgery Evaluation at Massachusetts Eye and Ear Infirmary. He also served as Research Director for the Program in Global Surgery and Social Change at Harvard. Trained in otolaryngology, head and neck surgery, and microvascular reconstructive surgery, he earned an MPH in global health (2011) and a PhD in Health Policy focused on decision-making (2015).Clinically, he specializes in large head and neck tumors with Mercy Ships, working closely with residents from the Pan-African Academy of Christian Surgeons. He has worked and taught in multiple countries, including Liberia, Sierra Leone, Guinea, Benin, and Madagascar. His research explores the global burden of surgical disease, financial barriers to care, and surgical access worldwide. As a co-author of the Lancet Commission on Global Surgery, he focuses on optimizing surgical policies to improve health outcomes while reducing financial hardship for patients.Beyond surgery, his coaching, writing, and speaking help people navigate major life decisions. He merges personal experience with decision science to guide others in building a life of purpose and fulfillment. His book, Solving for Why, has sold nearly 15,000 copies. Outside of his professional endeavors, he is a photographer, rock climber, and ninja warrior. He competed on Seasons 8, 9, and 11 of American Ninja Warrior.Connect with Mark Here: Instagram / Threads: @markshrimeLinkedIn: https://www.linkedin.com/in/markshrime/Medium: @shrimePersonal website: markshrime.comWebsite: solvingforwhy.coGrab the freebie here: markshrime.com/anatomy-pdf===================================If you enjoyed this episode, remember to hit the like button and subscribe. Then share this episode with your friends.Thanks for watching the Personal Development Trailblazers Podcast. This podcast is part of the Digital Trailblazer family of podcasts. To learn more about Digital Trailblazer and what we do to help entrepreneurs, go to DigitalTrailblazer.com.Are you a coach, consultant, expert, or online course creator? Then we'd love to invite you to our FREE Facebook Group where you can learn the best strategies to land more high-ticket clients and customers. QUICK LINKS: APPLY TO BE FEATURED: https://app.digitaltrailblazer.com/podcast-guest-applicationDIGITAL TRAILBLAZER: https://digitaltrailblazer.com/

Dr. Aditi Nerurkar is a Harvard physician, nationally recognized stress expert, and author of “The 5 Resets: Rewire Your Brain and Body For Less Stress and More.” She is also an in-demand multi-media personality, high profile medical correspondent, internationally renowned Fortune50 speaker, and podcaster. Uniquely fulfilling her original career ambition to be a journalist, Dr. Nerurkar has been featured in The Wall Street Journal, The Washington Post, Oprah Magazine, Architectural Digest and Elle – in addition to being a columnist for Forbes and writing for The Atlantic. She has made more than 300 appearances as a medical commentator on MSNBC, CNN, NBC, ABC and CBS News; and has spoken at the “Forbes 30 Under 30 Summit” and Harvard Business School Women's Conference. Dr. Nerurkar also co-hosts the popular and influential “Time Out: A Fair Play Podcast” with New York Times best-selling author Eve Rodsky. Dr. Nerurkar's first brush with intense media demand came in 2011 – when she was a Research Fellow at Harvard – with the publication of a study she conducted in the Journal of the American Medical Association (JAMA) titled: “When Conventional Medical Providers Recommend Unconventional Medicine”; followed by her first interview with Diane Sawyer on World News Tonight, and attention from NPR.Dr. Nerurkar's expertise on stress comes from working with thousands of patients throughout her years as a primary care physician and director of an integrative medicine program at Harvard's Beth Israel Deaconess Medical Center, from 2012-2020. She is now a lecturer at Harvard Medical School in the Division of Global Health & Social Medicine and serves as the Co-Director of the Clinical Clerkship in Community Engagement. She has also worked in global public health at a World Health Organization collaboration center in Geneva, Switzerland. Though she entered Barnard College at Columbia University with an eye toward studying journalism, Dr. Nerurkar's family DNA all but dictated a future in medicine. In India, her grandfather was a surgeon and her grandmother, one of only three women in her medical school, was an OB/GYN. She was raised by her grandparents in Mumbai until the age of six while her parents were in the U.S. studying medicine themselves. She then came to the States, where she grew up outside of Philadelphia, Pennsylvania.  Even as she thrived as a researcher and practicing physician, she developed a love for media and health communication and knew she would eventually use her creative and journalistic talents to facilitate action. Her first published article in The Huffington Post, “Medication or Meditation: Which Should You Choose?” launched this side of her career. During the pandemic, her speaking career took off as a speaker with The Leigh Bureau Speaking Agency.  Topics covered in this episode:Food choices and HealthImportance of SleepMindfulness and MeditationDigital Detox and Social MediaExercise Building ResiliencePersonal Well-Being JourneyHabits for a Healthy LifeSelf-CareStrategies for Stress ReliefBalancing Information ConsumptionCultivating Self-CompassionOvercoming BurnoutHuman Connection and StressReferenced in the episode:The Lindsey Elmore Show Ep 216 | Pulling Back The Curtain: How Medicine is Really Practiced in the U.S. | Otis BrawleyTo learn more about Dr. Aditi Nerurkar and her work, head over to https://www.draditi.com/____________________________________________________________________________________________________________________We hope you enjoyed this episode. Come check us out at https://www.spreaker.com/show/the-lindsey-elmore-showBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.

When Luke Messac began his emergency medicine residency at Rhode Island Hospital in 2018, he noticed his patients often came to him concerned about costs. Some worried about his recommendations for them to stay in the hospital overnight. Others questioned his motives when he asked them to undergo a test, like an X-ray or MRI. A few came in way too late in the course of their illnesses out of fear of the cost. He'd heard about aggressive debt collection practices at hospitals around the country that put people at risk of profound financial and legal consequences. It made him wonder: Was his hospital doing that, too? After a quick trip to the country courthouse to examine the case files, what he found troubled him. “I was inundated with what I thought were pretty horrific cases,” said Messac, author of the 2023 book, Your Money or Your Life: A History of Medical Debt Collection in the United States. “Low-income single moms, people living on disability, recent immigrants, were facing thousands of dollars of bills and court fees and interest fees. And if they did not pay and if they did not settle their suits quickly, then they could have their wages garnished. They would be charged double-digit interest rates.”In Berkeley Talks episode 219, Messac, now an attending physician at Brigham and Women's Hospital and an instructor in emergency medicine at Harvard Medical School, discusses how the changing role of hospitals, and the passage of Medicare and Medicaid in the 1960s, transformed how medical debts are collected in the U.S.This talk took place on Sept. 17, 2024, and was sponsored by the Berkeley Center for Social Medicine at the Institute for the Study of Societal Issues (ISSI) and cosponsored by Berkeley Public Health. Listen to the episode and read the transcript on UC Berkeley News (news.berkeley.edu/podcasts) or on YouTube @Berkeley News (youtube.com/@BerkeleyNews/podcasts).Music by Blue Dot Sessions.Photo by Ahmed for Unsplash+. Hosted on Acast. See acast.com/privacy for more information.

We are told that our personal health is our individual responsibility based on our own choices. Yet, the biological truth is that human health is dependent upon the health of nature's ecosystems and our social structures. Decisions that negatively affect these larger systems and eventually affect us are made without our consent as citizens and, often, without our knowledge. Dr. Rupa Marya, Associate Professor of Medicine at UC San Francisco, and Faculty Director of the Do No Harm Coalition, says “social medicine” means dismantling harmful social structures that directly lead to poor health outcomes, and building new structures that promote health and healing. Learn more about Rupa Marya and her work here. 

Historians of medicine often express the desire for their work to reach broader audiences; however, popular platforms—be they television, radio, podcasts, corporate or social media—can reach many but touch few. History of Medicine Week is dedicated to exploring the risks, benefits, experiences, and best practices for historians of medicine to make meaningful connections beyond familiar scholarly communities. This episode: Dana Landress Moderator University of Wisconsin Vanessa Heggie Institute of Applied Health Research, University of Birmingham Jessica Martucci Barbara Bates Center for the Study of the History of Nursing, University of Pennsylvania Lauren Small Center for Medical Humanities and Social Medicine, Johns Hopkins University For more information on this and other topics, please see https://www.chstm.org/video/200

  Dr. Moses S. Dixon, PhD, is a leading practitioner in Global Health and Social Medicine with a comprehensive background in the non-profit and governmental sectors locally and nationally. He […] The post Dr. Moses Dixon President & CEO of Senior Connection appeared first on PLAN of MA and RI.

Vikram Patel is the Paul Farmer Professor and Chair of the Department of Global Health and Social Medicine at Harvard Medical School, where he also leads the Mental Health for All Lab. Learn more about the Mental Health for All Lab & the EMPOWER program: https://mentalhealthforalllab.hms.harvard.edu/ Sign up for the Global Mental Health @ Harvard newsletter: http://eepurl.com/gY0NYD 

I'm not a financial advisor; Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions.Watch the show on television by downloading the e360tv channel app to your Roku, AppleTV or AmazonFireTV. You can also see it on YouTube.When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Devin: What is your superpower?Kevin: I think it's doing the work, man. I had people a long time ago tell me, “Your work speaks for itself.” So you don't have to talk.In my conversation with Kevin Shird, the author of A Life for a Life, one powerful idea stood out—how education can be a path to redemption, even in the most challenging of circumstances. Kevin's journey, including his time in prison, is a testament to the transformative power of learning. He didn't allow the experience of incarceration to define his life negatively. Instead, he used the opportunity to educate himself and turn his life around.Kevin shared with me, “Education will be the answer out of this mess.” For him, the decision to embrace learning during his imprisonment was the catalyst for his personal and professional growth. Without that commitment, he believes he wouldn't be where he is today, contributing positively to society.Not everyone who finds themselves in similar circumstances is able to make the same transition, however. One of Kevin's former cellmates, Damien, tragically experienced a different outcome. Despite Kevin's encouragement, Damien struggled with the lingering trauma from his past, which included the loss of his parents and witnessing horrific violence. His story, as detailed in Kevin's forthcoming book, highlights how unresolved trauma and a lack of mental health support can derail someone's life, even after serving their time.Kevin's experience underscores the crucial need for education and mental health services, both in prison and beyond, as vital tools for rehabilitation and preventing recidivism. His story is a call to action for better support systems for those who need them most.Kevin Shird's book, A Life for a Life, is now available for pre-order on Amazon and other major platforms, with an official release scheduled for April 2025.tl;dr:* Kevin Shird shared the transformative power of education during his time in prison, which he credits for changing his life and helping him become a contributor to society.* In this episode, Kevin contrasts his journey with that of his former cellmate, Damien, whose struggles with trauma, addiction, and lack of support led him back to prison.* Kevin emphasizes that doing the work and making sacrifices have been central to his success, highlighting his relentless dedication to writing, education, and helping others.* He recounted a pivotal moment when he was invited to speak at the United States Conference of Mayors about the opioid crisis, marking a turning point in his journey from drug trafficking to being a voice for change.* Kevin's advice for success is simple: focus, sacrifice, and ignore distractions, as consistent effort will ultimately lead to meaningful results and personal growth.How to Develop Doing the Work As a SuperpowerKevin Shird's superpower is the relentless commitment to doing the work. He believes that consistent, focused effort is the key to achieving meaningful results. For Kevin, the value of hard work lies in its ability to speak for itself without the need for boasting or promotion. He emphasizes that dedication, sacrifice, and perseverance are essential for success in any endeavor.Kevin shared an anecdote that exemplifies his superpower when he was invited to speak at the United States Conference of Mayors in 2016. After publishing his first book, he was asked to participate in a panel with the White House Office of National Drug Control Policy and the Justice Department to address the heroin epidemic. He described the experience as surreal, reflecting on how his past in drug trafficking was now being leveraged to make a positive impact. This opportunity led to more influential work, eventually earning him an invitation to the White House.Tips for Developing the Superpower:* Sacrifice: Be prepared to make sacrifices, whether it's time with family, leisure activities, or other personal priorities, to achieve your goals.* Focus: Ignore distractions and outside noise, staying committed to the work that needs to be done.* Persevere: Keep pushing through, even when the work is difficult or doesn't immediately show results.By following Kevin Shird's example and advice, you can make "Doing the Work" a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileKevin Shird (he/him):Author and writer Kevin Shird Enterprises About Kevin Shird Enterprises: Content Creation Website: a.co/d/9peNrrsX/Twitter Handle: @kevin_shirdCompany Facebook Page: fb.com/KevinA.ShirdOther URL: simonandschuster.com/books/A-Life-for-a-Life/Kevin-Shird/9798888458440Biographical Information: Kevin Shird is a four-time published author, activist, and screenwriter. He has become an expert on using the past to build a better future. Shird began his very unorthodox journey at the tender age of sixteen when he started dealing drugs on the streets of Baltimore. This led to him serving a total of almost twelve years in prison. Since leaving prison, Shird monetized his life's lesson by authoring books on social issues. He lectures at colleges and universities across America on issues like education, public health policy, and mass incarceration. During the Obama Administration, he collaborated with the White House and President Obama's Clemency Initiative. In 2018, he became an associate at Johns Hopkins University's Center for Medical Humanities and Social Medicine, where he co-teaches a class on public health. Today, he serves as a professor at Coppin State University. Linkedin: linkedin.com/in/kevin-shird-6b76455aInstagram Handle: @kevin_shirdMax-Impact MembersThe following Max-Impact Members provide valuable financial support to keep us operating:Carol Fineagan, Independent Consultant | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear | Ralf Mandt, Next Pitch | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.* SuperCrowd Mastermind Group, twice monthly on the 1st and 3rd Thursdays at noon Eastern. This group is for entrepreneurs and small business owners interested in raising money from the crowd. Attend your first meeting for free!* Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on October 15, 2024, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.* SuperCrowdHour, October 16, 2024, at 1:00 PM Eastern. Each month, we host a value-laden webinar for aspiring impact investors or social entrepreneurs. At October's webinar, Devin Thorpe will provide an in-depth answer to the question, “How to Assess Your Crowd's Potential for Investing?” Free to attend.* Superpowers for Good Televised Live Pitch, November 13, 9:00 PM Eastern during primetime. We are now accepting applications from businesses raising capital via Regulation Crowdfunding for the Q4 Superpowers for Good Live pitch. Visit s4g.biz/q4app to apply. At the event, judges will select their pick, and the audience will select the SuperCrowd Award recipient. Put the date on your calendar to watch it live!Community Event Calendar* Successful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events* Community Revitalization, Thursdays, 10:00 AM Eastern.* Main Street Skowhegan and NC3 Entrepreneur Finance Workshop Series, September 17 - November 19, 2023.* Investment Week 24, October 19-20, 2024, Los Angeles. * Crowdfunding Professional Association, Summit in DC, October 22-23* Asheville Neighborhood Economics, date TBD following impact of Helene.If you would like to submit an event for us to share with the 8,000+ members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

On this episode host Keri Boyce invites Dr. Buchbinder a Professor of Social Medicine and Adjunct Professor of Anthropology at UNC, Chapel Hill to disscuss an anthropological perspective on M.A.I.D. She weaves together stories collected from patients, caregivers, health care providers, activists, and legislators, to illustrate how they navigate medical aid-in-dying as a new medical frontier in the aftermath of legalization. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

B.C. Green Party leader Sonia Furstenau introduced her party's platform on the province's opioid crisis; NDP Leader David Eby and B.C. Conservatives Leader John Rustad have competing platforms. Dr. M-J Molloy, associate professor of medicine at UBC's Divison of Social Medicine joins us to discuss evidence-based research on safe supply, involuntary treatment and safe consumption sites. Then, it's the time of year for bears to fatten up before hibernation. We talk with Holly Reisner, co-executive director of the North Shore Black Bear Society on how to co-exist with bears.

Send us a Text Message.On this episode of the CMAJ Podcast, Dr. Blair Bigham and Dr. Mojola Omole tackle the complex issue of "socially admitted" patients, sometimes uncharitably referred to as "granny dumping." They explore the factors leading to these non-acute medical admissions, the challenges faced by healthcare providers and innovative solutions to the problem.Dr. Jasmine Mah, a geriatrics fellow at Dalhousie University, shares insights from her qualitative study published in CMAJ, titled "Managing “socially admitted” patients in hospital: a qualitative study of healthcare providers' perceptions". She provides examples of typical “social admissions”, such as patients with chronic conditions whose care circumstances have changed, and highlights the high mortality rates associated with these cases.The discussion moves to the attitudes of healthcare providers towards “socially admitted” patients, the systemic failures leading to these admissions, and potential solutions. Dr. Mah emphasizes the need for better understanding and support for these patients, suggesting systemic changes like integrating social vulnerability into case mix indices and improving community care to prevent unnecessary hospital admissions.Dr. Andrew Boozary, a primary care physician and executive director of the Gattuso Center for Social Medicine at University Health Network in Toronto, expands on these ideas in an editorial response. He underscores that these issues are not personal failures but policy failures, advocating for increased support roles like peer support workers and social medicine navigators. Dr. Boozary highlights the importance of innovative team-based care models to address the gaps in the current healthcare system.Throughout the episode, the hosts and guests call for a more integrated and empathetic approach to patient care, stressing the need for systemic changes to better manage “socially admitted” patients and improve overall healthcare outcomes.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-american-studies

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/latino-studies

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sociology

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/american-studies

Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals (New York University Press) provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health. Jill A. Fisher is Associate Professor of Social Medicine and Bioethics at the University of North Carolina at Chapel Hill. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

Welcome to an interview with the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose, Dr. Mark G. Shrime. Solving for Why is an inspiring memoir about finding the answer to life's biggest question—"Why?"—and about following that answer through remarkable, unlikely places on the road to fulfillment, purpose, and joy.   "Turning your heart toward the poor doesn't have to be on a hospital ship in West Africa. It doesn't have to be grandiose. It doesn't have to be newsworthy. It doesn't have to be what your friends, pastors, rabbis, priests, or colleagues say it should. It just has to be." Dr. Mark Shrime   Dr. Mark G. Shrime is the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. He is the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose (Hachette 2022).   He previously served as the O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, as the founder and Director of the Center for Global Surgery Evaluation at the Massachusetts Eye and Ear Infirmary, and as Research Director for the Program in Global Surgery and Social Change at Harvard.    He has spoken at the United Nations, WHO, Harvard, Princeton, and around the world addressing issues of healthcare inequity, moral injury in the healthcare workforce, and the non-health outcomes of health policies. In 2018, he was awarded the Arnold P. Gold Humanism in Medicine Award by the American Academy of Otolaryngology—Head and Neck Surgery.   Get Solving for Why here: https://rb.gy/okpa08   Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach   McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf   Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

Welcome to Strategy Skills episode 457, featuring an interview with the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose, Dr. Mark G. Shrime. Solving for Why is an inspiring memoir about finding the answer to life's biggest question—"Why?"—and about following that answer through remarkable, unlikely places on the road to fulfillment, purpose, and joy.   "Turning your heart toward the poor doesn't have to be on a hospital ship in West Africa. It doesn't have to be grandiose. It doesn't have to be newsworthy. It doesn't have to be what your friends, pastors, rabbis, priests, or colleagues say it should. It just has to be." Dr. Mark Shrime   Dr. Mark G. Shrime is the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. He is the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose (Hachette 2022).   He previously served as the O'Brien Chair of Global Surgery at the Royal College of Surgeons in Ireland, as the founder and Director of the Center for Global Surgery Evaluation at the Massachusetts Eye and Ear Infirmary, and as Research Director for the Program in Global Surgery and Social Change at Harvard.    He has spoken at the United Nations, WHO, Harvard, Princeton, and around the world addressing issues of healthcare inequity, moral injury in the healthcare workforce, and the non-health outcomes of health policies. In 2018, he was awarded the Arnold P. Gold Humanism in Medicine Award by the American Academy of Otolaryngology—Head and Neck Surgery.   Get Solving for Why here: https://rb.gy/okpa08   Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach   McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf   Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo  

On this episode of Florida Matters we talk with two experts about the health impacts of vaping- both on adults and youth. We discuss the role of e-cigarettes as an alternative to conventional smoking for adults who want to quit and we take a look at a new Florida law aimed to stop children from vaping. We talked with Yiota Kitsantis, professor and chair of the Department of Population Health and Social Medicine at Florida Atlantic University's Schmidt School of Medicine. Kitsantis has a PHD in statistics and specializes in biostatistics and epidemiology. FAU published a study recently that explores the rise in vaping among youth, and Kitsantis discussed the risks of vaping. To learn more about how vaping is seen as an alternative to cigarettes for many adult smokers- and its role for smokers who want to quit- Florida Matters visited the Moffitt Cancer Center in Tampa. There, we spoke with. Vani Simmons, a PHD in Clinical Psychology and a senior member in the Department of Health Outcomes and Behavior at Moffitt.

In our fourth episode, we delve into the importance of gender-inclusive language in genetic counseling and the specific challenges transgender and gender-diverse (TGD) individuals face in accessing hereditary cancer care. You can find these articles in a special virtual issue of the Journal of Genetic Counseling which is free and open access for the month of June. You can find the Journal of Genetic Counseling webpage via onlinelibrary.wiley.com or via the National Society of Genetic Counselors website.    Segment 1 “Use of gender-inclusive language in genetic counseling to optimize patient care”   Heather Motiff graduated with a B.S. in Psychology from the University of Wisconsin-Whitewater in 2006. She has extensive experience working as a crisis response advocate and co-facilitating support groups for survivors of intimate partner violence. Heather discovered her interest in genetic counseling during her first pregnancy in 2010. She has served as a Community Resource Specialist and contributed significantly to gender-affirming care initiatives during her graduate studies at UW-Madison. Heather is now an oncology genetic counselor at SSM Health Cancer Care in Madison, WI, and is dedicated to providing inclusive, quality healthcare and genetic services.   In this segment we discuss: Specific examples and terms used in gender-inclusive language. Comfort levels of genetic counselors with using gender-inclusive language. Findings from thematic analyses on the use of gendered language and its impact on patient care. Suggestions for additional training resources for healthcare professionals. Segment 2 “Experiences of hereditary cancer care among transgender and gender diverse people: “It's gender. It's cancer risk…it's everything”   Sarah Roth is a genetic counselor and a PhD candidate in Anthropology at Johns Hopkins University. She is a BRCA1 carrier whose research focuses on the experiences of patients, communities, and providers in cancer care and genomic medicine. Sarah has been a founding editor of Tendon at JHU's Center for Medical Humanities & Social Medicine, a contributing writer at Synapsis: A Health Humanities Journal, and a recent predoctoral fellow in Bioethics at the National Institutes of Health.   In this segment, we discuss: Challenges faced by TGD individuals in accessing hereditary cancer care. Participants' perspectives on gendered language in healthcare. Actionable recommendations for healthcare providers to support TGD individuals with hereditary cancer syndromes.   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. 

My guest today is Dr. Mark G. Shrime, MD. Dr. Mark is the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. He is the author of Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose (Hachette 2022).He has spoken at the United Nations, WHO, Harvard, Princeton, and around the world addressing issues of healthcare inequity, moral injury in the healthcare workforce, and the non-health outcomes of health policies. In 2018, he was awarded the Arnold P. Gold Humanism in Medicine Award by the American Academy of Otolaryngology—Head and Neck Surgery.Some of the topics we explore in this episode include:- Moving to the US from Lebanon as a child- What it was like growing up within an immigrant family context- Pressures faced to go into medicine- Dr. Mark's process of finding his purpose- How fear and uncertainty keep us from making changes in life- And how embracing failure can be a catalyst for growth—————————————————————————Dr. Shrime's website: https://www.markshrime.com/Solving for Why: https://a.co/d/7jWLggv—————————————————————————Thank you all for checking out the episode! Here are some ways to help support Mentally Flexible:You can help cover some of the costs of running the podcast by donating a cup of coffee! www.buymeacoffee.com/mentallyflexiblePlease subscribe and leave a review on Apple Podcasts. It only takes 30 seconds and plays an important role in being able to get new guests.https://podcasts.apple.com/us/podcast/mentally-flexible/id1539933988Follow the show on Instagram: https://www.instagram.com/mentallyflexible/Check out my song “Glimpse at Truth” that you hear in the intro/outro of every episode: https://tomparkes.bandcamp.com/track/glimpse-at-truth

This week, we revisit our interview with Dr. Mark Shrime. Mark is an internationally renowned speaker, surgeon, and author. He serves as the International Chief Medical Officer at Mercy Ships and a Lecturer in Global Health and Social Medicine at the Harvard Medical School. Mark has written a new book Solving for Why: A Surgeon's Journey to Discover the Transformative Power of Purpose. He received his MD from the University of Texas and received his Ph.D. in health policy from Harvard University, with a concentration in decision science. When not working, he is an avid photographer and rock climber and has competed on Seasons 8, 9, and 11 of American Ninja Warrior.

Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations. Related Content: One Day, AI Could Mean Better Mental Health for All

Arthur Kleinman is a towering figure in psychiatry and medical anthropology. He has made substantial contributions to both fields over his illustrious career spanning more than five decades. As a Professor of Medical Anthropology at Harvard University's Department of Global Health and Social Medicine and a Professor of Psychiatry at Harvard Medical School, Kleinman has profoundly influenced how medical professionals understand the interplay between culture, illness, and healing. His extensive body of work includes seminal books and numerous articles that have become foundational texts in medical anthropology. These writings explore the crucial role of personal and cultural narratives in shaping medical practices and patient care. In recent years, Kleinman has increasingly focused on critiquing the prevailing practices within psychiatry, particularly the over-medicalization of mental health issues and the neglect of broader social and personal contexts that significantly impact patient care. His critiques advocate for a more nuanced and compassionate approach to psychiatry, one that recognizes the importance of individual patient stories and the socio-cultural dimensions of mental health. In this interview, Kleinman explores critical issues facing modern healthcare. He discusses the often-overlooked narrative of patient experiences, critiques the mechanistic approaches that dominate U.S. healthcare, and offers insightful reflections on the global mental health movement. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. To find the Mad in America podcast on your preferred podcast player, click here

Dr. Aditi Nerurkar is a Harvard physician, stress expert, speaker, national television correspondent, and host of the podcast, Time Out with Eve Rodsky. She is also a lecturer at Harvard Medical School in the Division of Global Health and Social Medicine, and serves as the co-director of the Clinical Clerkship in Community Engagement. She has spoken at the Forbes 30 Under 30 Summit, the HBS Women's Conference, and many other events.Most importantly, her new book, The 5 Resets: Rewire Your Brain and Body For Less Stress and More Resilience, came out this past week, where she focuses on how to maintain healthy levels of stress.In our conversation, we reflect on how the pandemic and other traumatic events of the last three  years have impacted us all. Aditi shines a light on the unique challenges that make us more stressed out than our parents and opens up about the insights into stress she gained on her journey as a patient and as an expert while sharing practical tools for navigating the new normal.Reading this book was probably the best thing I've done for myself to start out the year!What we talked about: How stress and burnout is the norm not the exception. You are not alone and it is not your fault. (03:54)How information overload impacts the natural stress of parenting (08:55)Healthy versus unhealthy stress + achieving the “sweet spot.” (18:04)Dismantling the myth of multitasking + monotask to overcome stress and burnout.(21:26)Aditi's stress journey + her personal techniques for relaxation. + supporting the gut-brain connection to decrease stress-triggered illness. (25:55)Aditi's family immigration story + tackling  taboos of mental illness in South Asian culture and around the world. (36:14)Aditi's deep connection to Bombay as key to her Indian identity. (42:09)Rapid fire questions. (49:05)Connect with Aditi Nerurkar: WebsiteInstagramFacebookLinkedinPodcastLet's Connect:InstagramThis podcast is produced by Ginni Media

Dr. Aditi Nerurkar is a Harvard physician, nationally recognized stress expert, and author of “The 5 Resets: Rewire Your Brain and Body For Less Stress and More.” She is also an in-demand multi-media personality, high profile medical correspondent, internationally renowned Fortune50 speaker, and podcaster. Uniquely fulfilling her original career ambition to be a journalist, Dr. Nerurkar has been featured in The Wall Street Journal, The Washington Post, Oprah Magazine, Architectural Digest and Elle – in addition to being a columnist for Forbes and writing for The Atlantic. She has made more than 300 appearances as a medical commentator on MSNBC, CNN, NBC, ABC and CBS News; and has spoken at the “Forbes 30 Under 30 Summit” and Harvard Business School Women's Conference. Dr. Nerurkar also co-hosts the popular and influential “Time Out: A Fair Play Podcast” with New York Times best-selling author Eve Rodsky. Dr. Nerurkar's first brush with intense media demand came in 2011 – when she was a Research Fellow at Harvard – with the publication of a study she conducted in the Journal of the American Medical Association (JAMA) titled: “When Conventional Medical Providers Recommend Unconventional Medicine”; followed by her first interview with Diane Sawyer on World News Tonight, and attention from NPR.Dr. Nerurkar's expertise on stress comes from working with thousands of patients throughout her years as a primary care physician and director of an integrative medicine program at Harvard's Beth Israel Deaconess Medical Center, from 2012-2020. She is now a lecturer at Harvard Medical School in the Division of Global Health & Social Medicine and serves as the Co-Director of the Clinical Clerkship in Community Engagement. She has also worked in global public health at a World Health Organization collaboration center in Geneva, Switzerland. Though she entered Barnard College at Columbia University with an eye toward studying journalism, Dr. Nerurkar's family DNA all but dictated a future in medicine. In India, her grandfather was a surgeon and her grandmother, one of only three women in her medical school, was an OB/GYN. She was raised by her grandparents in Mumbai until the age of six while her parents were in the U.S. studying medicine themselves. She then came to the States, where she grew up outside of Philadelphia, Pennsylvania. Even as she thrived as a researcher and practicing physician, she developed a love for media and health communication and knew she would eventually use her creative and journalistic talents to facilitate action. Her first published article in The Huffington Post, “Medication or Meditation: Which Should You Choose?” launched this side of her career. During the pandemic, her speaking career took off as a speaker with The Leigh Bureau Speaking Agency. Topics covered in this episode:Food choices and HealthImportance of SleepMindfulness and MeditationDigital Detox and Social MediaExercise Building ResiliencePersonal Well-Being JourneyHabits for a Healthy LifeSelf-CareStrategies for Stress ReliefBalancing Information ConsumptionCultivating Self-CompassionOvercoming BurnoutHuman Connection and StressReferenced in the episode:The Lindsey Elmore Show Ep 216 | Pulling Back The Curtain: How Medicine is Really Practiced in the U.S. | Otis Brawley_______________________________________________Just like plants depend on sunlight to flourish, the human body is dependent on light for its health and well being. Getting natural sunlight early in the day is the best way to harness the power of the sun. Supplementing with Fringe Lighty Therapy Boxes or Fringe Wraps give you a way that you can quickly and easily feel the benefits of red light therapy in your home.You can save $15 on any purchase when you head http://www.lindseyelmore.com/fringeheals Be sure that you shop the code LKE24 to save $15 on any order!_______________________________________________We hope you enjoyed this episode. Come check us out at https://www.spreaker.com/show/the-lindsey-elmore-show

On this week's episode of Enneagram IRL, we meet with Dr. Aditi Nerurkar, Harvard physician, nationally recognized stress expert, and author. She is also an in-demand multi-media personality, high profile medical correspondent, internationally renowned Fortune50 speaker, and podcaster. Uniquely fulfilling her original career ambition to be a journalist, Dr. Nerurkar has been featured in The Wall Street Journal, The Washington Post, Oprah Magazine, Architectural Digest and Elle – in addition to being a columnist for Forbes and writing for The Atlantic.Dr. Nerurkar's expertise on stress comes from working with thousands of patients throughout her years as a primary care physician and director of an integrative medicine program at Harvard's Beth Israel Deaconess Medical Center. She is now a lecturer at Harvard Medical School in the Division of Global Health & Social Medicine and serves as the Co-Director of the Clinical Clerkship in Community Engagement. She has also worked in global public health at a World Health Organization collaboration center in Geneva, Switzerland.To bring stress back to healthy levels, Dr. Nerurkar offers her five science-backed mindset shifts, rooted in more than two decades of clinical experience, for when life gets hard:The First Reset: Get Clear on What Matters MostThe Second Reset: Find Quiet in a Noisy WorldThe Third Reset: Sync Your Brain and Your BodyThe Fourth Reset: Come Up for AirThe Fifth Reset: Bring Your Best Self ForwardTo learn more about Dr. Aditi Nerurkar and “The 5 Resets,” visit https://www.draditi.com/.

In our Mental Health Mini-Series we have our friend Dr. Sammy Kim join us! Rev. Dr. Sam D. Kim is the Co-founder of 180 Church, near Union Square in downtown Manhattan. Dr. Kim is a Yale-Hastings Scholar at the Hastings Center exploring the crisis of physician burnout in academic medicine and health care from an ethical perspective in partnership with the University of Pennsylvania. He was appointed as a research Fellow in Global Health and Social Medicine at the Center for Bioethics at Harvard Medical School and part of Harvard catalyst, where he explored and taught on inequities surrounding health, immigration and social policies. He is also the author of the book "A Holy Haunting" available here: https://amzn.to/3G0p8Bc www.fyi-podcast.com | www.youngadults.today 

We are told that our personal health is our individual responsibility based on our own choices. Yet, the biological truth is that human health is dependent upon the health of nature's ecosystems and our social structures. Decisions that negatively affect these larger systems and eventually affect us are made without our consent as citizens and, often, without our knowledge. Dr. Rupa Marya, Associate Professor of Medicine at UC San Francisco, and Faculty Director of the Do No Harm Coalition, says "social medicine" means dismantling harmful social structures that directly lead to poor health outcomes, and building new structures that promote health and healing. Learn more about Rupa Marya and her work here. This is an episode of the Bioneers: Revolution from the Heart of Nature series. Visit the radio and podcast homepage to learn more.

Vincanne Adams's book Glyphosate and the Swirl: An Agroindustrial Chemical on the Move (Duke UP, 2023) is part of a broader trend in anthropology that is developing new methods and techniques to study our increasingly polluted and toxic world. Adams takes Glyphosate as a case study and follows this chemical as it moves from the past to the present, from the lab to the dinner table, from outside our bodies, to within our cells to grapple with what it is to live in such an entangled world.   Adams explores the chemical glyphosate—the active ingredient in Roundup and a pervasive agricultural herbicide—as a predicament of contested science and chemically saturated life. Adams traces the history of glyphosate's invention and its multiple uses as activists, regulators, scientists, clinicians, consumers, and sick people try to determine its safety and harm. Scientific and political debates over glyphosate's toxicity are agitated into a swirl—a condition in which certainty is continually contested, divided, and multiplied. This movement replicates the chemical's movement in soils, foods, bodies, archives, labs, and legislative bodies, settling in some places here and in other places there, its potencies changing and altering what it touches with different scales and kinds of impact. The swirl is both an artifact of academic capitalism, activist tactics, and contested scientific facts and a way to capture the complexity of contemporary life with chemicals. Prof. Vincanne Adams, is professor Anthropology, History and Social Medicine at the University of California, San Francisco. Elliott M. Reichardt, MPhil, is a PhD Candidate in Socio-Cultural Anthropology at Stanford University. Elliott's research interests are in capitalism, colonialism, and socio-ecological health in North America. Elliott also has long standing interests in medical anthropology and the history of science and medicine. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The rate of overdose deaths linked to fentanyl is skyrocketing and Native Americans are many times more likely to be affected. The cheap and potent drug is replacing its related cousins — heroin and oxycodone — as the biggest addiction threat. Among the bright spots: the Cherokee Nation is investing in a state-of-the-art in-patient treatment facility to combat the ravages of opioid addiction. GUESTS Chairwoman Angela Elliott-Santos (Manzanita Band of Kumeyaay Nation), chairwoman of the Manzanita Band of Kumeyaay Nation Juli Skinner, senior director of behavioral health for the Cherokee Nation Dr. Joseph Gone (Aaniiih), professor of Anthropology and of Global Health and Social Medicine at Harvard University Joseph Friedman, researcher at UCLA